You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
McKesson
AstraZeneca
Harvard Business School
Colorcon

Last Updated: July 5, 2020

DrugPatentWatch Database Preview

SENSORCAINE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Sensorcaine, and when can generic versions of Sensorcaine launch?

Sensorcaine is a drug marketed by Fresenius Kabi Usa and is included in eight NDAs.

The generic ingredient in SENSORCAINE is bupivacaine hydrochloride. There are twelve drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride profile page.

Drug patent expirations by year for SENSORCAINE
Drug Prices for SENSORCAINE

See drug prices for SENSORCAINE

Recent Clinical Trials for SENSORCAINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Christopher Connors, MDPhase 4
University of TennesseePhase 3
Liquidia Technologies, Inc.Phase 1

See all SENSORCAINE clinical trials

US Patents and Regulatory Information for SENSORCAINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa SENSORCAINE bupivacaine hydrochloride; epinephrine bitartrate INJECTABLE;INJECTION 070966-001 Oct 13, 1987 AP RX No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa SENSORCAINE bupivacaine hydrochloride INJECTABLE;INJECTION 070553-001 May 21, 1986 AP RX No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa SENSORCAINE bupivacaine hydrochloride INJECTABLE;INJECTION 018304-001 Approved Prior to Jan 1, 1982 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
McKesson
AstraZeneca
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.